Product Information
PR-619 is a small molecule that inhibits the ubiquitin ligases Nedd4 and HECTD1, leading to the activation of autophagy. PR-619 also inhibits protease activity in cancer cells. It has been shown to specifically target microbial infections such as tuberculosis and malaria. PR-619 has shown promise for treating urothelial carcinoma, heparin-induced thrombocytopenia, mesenchymal markers, and body formation.
Chemical properties
Technical inquiry about: 3D-CAA64532 PR-619
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.